Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0574 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0056 | 0.03 | 0.0636 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.004 | 0 | 0.5 |
Brugia malayi | proprotein convertase 2 | 0.0183 | 0.2677 | 0.5686 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0183 | 0.2677 | 0.5686 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0069 | 0.0533 | 0.1032 |
Echinococcus granulosus | furin | 0.0291 | 0.4708 | 1 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0533 | 0.9242 | 1 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0291 | 0.4708 | 1 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0177 | 0.2564 | 1 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.004 | 0 | 0.5 |
Brugia malayi | endoprotease bli-4 precursor | 0.0291 | 0.4708 | 1 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.004 | 0 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0069 | 0.0533 | 0.1032 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.004 | 0 | 0.5 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.004 | 0 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0069 | 0.0533 | 0.1032 |
Loa Loa (eye worm) | hypothetical protein | 0.0291 | 0.4708 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.004 | 0 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0069 | 0.0533 | 0.1032 |
Brugia malayi | neuroendocrine convertase 1 precursor | 0.0183 | 0.2677 | 0.5686 |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.0177 | 0.2564 | 0.7024 |
Echinococcus multilocularis | Furin 1 | 0.0069 | 0.0533 | 0.1461 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0291 | 0.4708 | 1 |
Leishmania major | UDP-galactopyranose mutase | 0.004 | 0 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.004 | 0 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0069 | 0.0533 | 0.1032 |
Loa Loa (eye worm) | hypothetical protein | 0.0114 | 0.1386 | 0.2944 |
Schistosoma mansoni | furin-1 (S08 family) | 0.0127 | 0.162 | 0.3441 |
Brugia malayi | celfurPC protein | 0.0235 | 0.3651 | 0.7754 |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.0177 | 0.2564 | 0.5446 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0183 | 0.2677 | 0.7333 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.004 | 0 | 0.5 |
Onchocerca volvulus | 0.004 | 0 | 0.5 | |
Plasmodium vivax | hypothetical protein, conserved | 0.004 | 0 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0069 | 0.0533 | 0.1032 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0177 | 0.2564 | 1 |
Loa Loa (eye worm) | proprotein convertase 2 | 0.0069 | 0.0533 | 0.1133 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.004 | 0 | 0.5 |
Echinococcus multilocularis | 0.0235 | 0.3651 | 1 | |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.004 | 0 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.004 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.004 | 0 | 0.5 |
Schistosoma mansoni | subfamily S8B non-peptidase homologue (S08 family) | 0.0069 | 0.0533 | 0.1133 |
Giardia lamblia | High cysteine membrane protein Group 2 | 0.0108 | 0.1273 | 1 |
Echinococcus granulosus | Furin 1 | 0.0069 | 0.0533 | 0.1133 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED20 (functional) | > 0.83 mM kg-1 | Compound evaluated for hypoglycemic activity by lowering blood glucose in normal rats by 20% after oral administration(highest dose tested) | ChEMBL. | 6864736 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.